US Xpress Enterprises Inc
F:7S3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
US Xpress Enterprises Inc
F:7S3
|
US |
|
Abbott Laboratories
NYSE:ABT
|
US |
|
T
|
Tallinna Kaubamaja Grupp AS
F:UE8
|
EE |
|
Guardant Health Inc
NASDAQ:GH
|
US |
|
US Masters Residential Property Fund
ASX:URF
|
AU |
|
Eventbrite Inc
NYSE:EB
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 7S3's stock price target?
Not Available
7S3 doesn't have any price targets made by Wall Street professionals.
What is US Xpress Enterprises Inc's Revenue forecast?
Projected CAGR
4%
For the last 8 years the compound annual growth rate for US Xpress Enterprises Inc's revenue is 3%. The projected CAGR for the next 3 years is 4%.